Skip to content

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

TRUE CHAMPION: An Educational Videogame Intervention for the Prevention of Doping and Supplement Abuse in Teenage Athletes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04203992
Enrollment
284
Registered
2019-12-18
Start date
2020-11-30
Completion date
2022-06-30
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Doping in Sport, Performance Enhancing Product Use

Keywords

Student athletes, Supplements, Videogame

Brief summary

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to dope. The investigators hypothesize that student athletes who play the intervention game will have lower use of banned substances and sport supplements, greater intentions to stay clean, and will also show improvements in the cognitive and motivational antecedents to doping when compared to a control condition.

Detailed description

284 student athletes will be enrolled in this two-arm quasi-experimental study. The participants will be boys and girls, aged 13 to 16 years who compete in any sport. Participants will be recruited and enrolled through partnerships with their school physical education and/or sport programs. Participants will complete baseline questionnaires assessing demographics, history of sport participation, and psychological variables related to doping prevention including knowledge, doping self-regulatory efficacy, motivation, attitudes, intentions, perceived norms, doping refusal, substance use behaviours, and doping related protective behaviours (e.g., checking the list of ingredients on medications). Participants will then be assigned to either an intervention group (n = 142; the doping videogame the investigators are developing) or a comparison group (n = 142). The comparison group will be given printed educational materials about doping education, developed by an accredited source (e.g., UNESCO). Assignment to the intervention or comparison group will be conducted at the level of the school to reduce the potential for contamination that could occur if intervention and comparison students were interacting in their school environment and sharing information they learned from the game. Participants from the intervention group will play five, 60-minute sessions over the course of one month (5 hours of total gameplay). Before the gameplay sessions begin, the Project Director and research assistants will orient the intervention group participants to the use of the intervention videogame. Players will be given a tutorial on an iPad demonstrating the mechanics of the game and how to use the iPad. Each player will have their own dedicated iPad that they will use during each game play session (this will be provided by the research team). Shortly after the last gameplay session is completed, participants from both groups will be asked to complete a questionnaire assessing the same psychological variables assessed at baseline as well as their gameplay experience. The psychological variables will also be assessed at three, six, and 12 month follow-ups.

Interventions

BEHAVIORALVideogame

True Champion is an educational, values-based game that aims to empower young athletes to make informed decisions to avoid doping. Participants engaging in the videogame sessions will encounter a series of thought-provoking situations and knowledge tests. Players will help their assigned character navigate through these curriculum-rich scenarios in order to reach their performance goals in a healthy and ethical way.

BEHAVIORALControl

Participants will be given an anti-doping booklet prepared by UNESCO. This booklet is considered standard educational material, i.e. what might be presented to young athletes as part of their regular sports curriculum.

Sponsors

International Olympic Committee
CollaboratorUNKNOWN
World Anti-Doping Agency
CollaboratorOTHER
Phantom Compass
CollaboratorUNKNOWN
Digitalmill, Inc.
CollaboratorUNKNOWN
McGill University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

We aim to enroll 284 male and female student-athletes between the ages of 13 and 16. Participants will be assigned to either an intervention group (n = 142) or a comparison group (n = 142).

Eligibility

Sex/Gender
ALL
Age
13 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject competes in a competitive sport at the high school level or higher * Able to read and understand English

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Intentions to use banned substances and sport supplements12 monthsSelf-reported intentions of using banned substances or supplements for performance enhancement or recovery in sport. This outcome will be measured using a self-reported questionnaire. Scale: Performance-Enhancing Substances and Methods Use Minimum value: 1 - extremely unlikely (better outcome) Maximum value: 7 - extremely likely (worse outcome)
Use of banned substances12 monthsSelf-reported use of banned substances for performance enhancement or recovery in sport. This outcome will be measured using a self-reported questionnaire. Scale: Performance-Enhancing Substances and Methods Use Minimum value: 1 - extremely unlikely (better outcome) Maximum value: 7 - extremely likely (worse outcome)
Use of sport supplements12 monthsSelf-reported use of supplements for performance enhancement or recovery in sport. This outcome will be measured using a self-reported questionnaire. Scale: Performance-Enhancing Substances and Methods Use Minimum value: 1 - extremely unlikely (better outcome) Maximum value: 7 - extremely likely (worse outcome)

Secondary

MeasureTime frameDescription
Attitudes12 monthsAttitudes towards doping in sport. This outcome will be measured using a subscale from a validated questionnaire. Scale: The Adolescent Sport Doping Inventory Minimum value: 1 - strongly disagree (worse outcome) Maximum value: 7 - strongly agree (better outcome) Note: some items are reverse-scored
Anti-doping protective behaviours12 monthsSelf-reported engagement in behaviours linked to doping abstinence. Scale: Microbehaviours Minimum value: 1 - never (worse outcome) Maximum value: 7 - always (better outcome)
Knowledge12 monthsKnowledge of anti-doping rules, definitions and consequences of doping. This outcome will be assessed using a True/False questionnaire.
Gameplay experience1 monthEnjoyment and acceptability of the True Champion videogame among players assigned to the intervention condition. This outcome will be assessed using a questionnaire we have created. Answers will range from strongly disagree to strongly agree.
Doping refusal12 monthsSelf-report of having refused a supplement or performance-enhancing substance. This outcome will be assessed using a Yes (worse outcome) or No (better outcome) questionnaire.
Doping Self-Regulatory Efficacy12 monthsSelf-efficacy for refusing doping under a variety of pressure situations. This outcome will be measured using a validated questionnaire. Scale: Doping Self-Regulatory Efficacy Minimum value: 1 - no confidence (better outcome) Maximum value: 5 - complete confidence (worse outcome)
Motivation12 monthsMotivations for abstaining from doping. This outcome will be measured using an adaptation of a validated questionnaire. Scale: Treatment Self-Regulation Questionnaire for the Avoidance of Doping in Sport Minimum value: 1 - not true at all (worse outcome) Maximum value: 7 - very true (better outcome)

Contacts

Primary ContactLindsay R Duncan, PhD
lindsay.duncan@mcgill.ca514-398-4184
Backup ContactEvelyne Bedard, MSc
evelyne.bedard@mcgill.ca514-398-4814

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026